Literature DB >> 21432859

Serial angioscopic evaluation of neointimal coverage and incidence of thrombus formation after Paclitaxel-eluting stent implantation: comparison between 6- and 18-month follow-up.

Masahiko Hara1, Masami Nishino, Masayuki Taniike, Nobuhiko Makino, Hiroyasu Kato, Yasuyuki Egami, Ryu Shutta, Jun Tanouchi, Yoshio Yamada.   

Abstract

BACKGROUND: Long-term serial angioscopic follow-up data after paclitaxel-eluting stent (PES) implantation has not previously been published. The aim of this study is to compare the angioscopic parameters such as neointimal coverage grade and prevalence of red mural thrombus at 6- and 18-month follow-up after PES implantation. HYPOTHESIS: Neointimal formation continues to grow and prevalence of angioscopic thrombus formation becomes low over time after PES implantation.
METHODS: We retrospectively enrolled 17 patients with 19 stents who underwent both 6- and 18-month follow-up coronary angioscopy after PES implantation. We evaluated the minimum and maximum neointimal coverage grade within 1 stent using coronary angioscopy by classifying neointimal coverage grade into 4 categories. Neointimal coverage grade and incidence of angioscopic red mural thrombus were compared between 6- and 18-month follow-up groups.
RESULTS: Minimum neointimal coverage grade at 18 months become lower than that at the 6-month follow-up (0.95 ± 0.62 at 6 mo vs 0.58 ± 0.51 at 18 mo, P = 0.035), whereas maximum grade was not significantly different (2.16 ± 0.83 at 6 mo vs 2.37 ± 0.76 at 18 mo, P = 0.248). High incidence of angioscopic red mural thrombus at 6 months was maintained even at 18-month follow-up (68% at 6 mo vs 84% at 18 mo, P = 0.224).
CONCLUSIONS: Long-term serial angioscopic follow-up demonstrated persistent high incidence of red mural thrombus formation at 18 months after PES implantation. 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21432859      PMCID: PMC6652643          DOI: 10.1002/clc.20881

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  18 in total

Review 1.  Molecular basis of restenosis and drug-eluting stents.

Authors:  Marco A Costa; Daniel I Simon
Journal:  Circulation       Date:  2005-05-03       Impact factor: 29.690

2.  Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.

Authors:  Jiro Aoki; Antonio Colombo; Dariusz Dudek; Adrian P Banning; Janusz Drzewiecki; Krzysztof Zmudka; Francois Schiele; Mary E Russell; Joerg Koglin; Patrick W Serruys
Journal:  Circulation       Date:  2005-12-12       Impact factor: 29.690

Review 3.  Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.

Authors:  Thomas F Lüscher; Jan Steffel; Franz R Eberli; Michael Joner; Gaku Nakazawa; Felix C Tanner; Renu Virmani
Journal:  Circulation       Date:  2007-02-27       Impact factor: 29.690

4.  Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

Authors:  Eric L Eisenstein; Kevin J Anstrom; David F Kong; Linda K Shaw; Robert H Tuttle; Daniel B Mark; Judith M Kramer; Robert A Harrington; David B Matchar; David E Kandzari; Eric D Peterson; Kevin A Schulman; Robert M Califf
Journal:  JAMA       Date:  2006-12-05       Impact factor: 56.272

5.  Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.

Authors:  Aloke V Finn; Michael Joner; Gaku Nakazawa; Frank Kolodgie; John Newell; Mike C John; Herman K Gold; Renu Virmani
Journal:  Circulation       Date:  2007-04-16       Impact factor: 29.690

6.  A comparison of bare-metal and drug-eluting stents for off-label indications.

Authors:  Oscar C Marroquin; Faith Selzer; Suresh R Mulukutla; David O Williams; Helen A Vlachos; Robert L Wilensky; Jean-François Tanguay; Elizabeth M Holper; J Dawn Abbott; Joon S Lee; Conrad Smith; William D Anderson; Sheryl F Kelsey; Kevin E Kip
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

7.  Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.

Authors:  Jochem W van Werkum; Antonius A Heestermans; A Carla Zomer; Johannes C Kelder; Maarten-Jan Suttorp; Benno J Rensing; Jacques J Koolen; B R Guus Brueren; Jan-Henk E Dambrink; Raymond W Hautvast; Freek W Verheugt; Jurriën M ten Berg
Journal:  J Am Coll Cardiol       Date:  2009-04-21       Impact factor: 24.094

8.  Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.

Authors:  Muzaffer Degertekin; Patrick W Serruys; David P Foley; Kengo Tanabe; Evelyn Regar; Jeroen Vos; Peter C Smits; Wim J van der Giessen; Marcel van den Brand; Pim de Feyter; Jeffrey J Popma
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

9.  Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.

Authors:  Masaki Awata; Jun-ichi Kotani; Masaaki Uematsu; Takakazu Morozumi; Tetsuya Watanabe; Toshinari Onishi; Osamu Iida; Fusako Sera; Shinsuke Nanto; Masatsugu Hori; Seiki Nagata
Journal:  Circulation       Date:  2007-08-07       Impact factor: 29.690

Review 10.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Authors:  Christoph Stettler; Simon Wandel; Sabin Allemann; Adnan Kastrati; Marie Claude Morice; Albert Schömig; Matthias E Pfisterer; Gregg W Stone; Martin B Leon; José Suarez de Lezo; Jean-Jacques Goy; Seung-Jung Park; Manel Sabaté; Maarten J Suttorp; Henning Kelbaek; Christian Spaulding; Maurizio Menichelli; Paul Vermeersch; Maurits T Dirksen; Pavel Cervinka; Anna Sonia Petronio; Alain J Nordmann; Peter Diem; Bernhard Meier; Marcel Zwahlen; Stephan Reichenbach; Sven Trelle; Stephan Windecker; Peter Jüni
Journal:  Lancet       Date:  2007-09-15       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.